|
Aug 06, 2020
|
Dynavax Announces Second Quarter 2020 Financial Results
|
|
|
Aug 03, 2020
|
TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales
|
|
|
Jul 30, 2020
|
Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
|
|
|
Jul 23, 2020
|
Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
|
|
|
Jul 21, 2020
|
Dynavax Announces the Appointment of Two New Board Members
|
|
|
Jul 16, 2020
|
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
|
|
|
Jul 14, 2020
|
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 Vaccine Candidate with Dynavax’s CpG 1018 Adjuvant
|
|
|
Jul 08, 2020
|
Dynavax and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
|
|
|
Jun 22, 2020
|
Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series
|
|
|
Jun 19, 2020
|
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 Adjuvant
|
|
